BCI-FIT adaptive signal modeling for Parkinson's Disease

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Parkinson's Disease+7 MoreBCI-FIT adaptive signal modeling - Behavioral
Eligibility
18 - 89
All Sexes
What conditions do you have?
Select

Study Summary

This trial is testing a new brain-computer interface (BCI) that does not require surgery for people with severe speech and physical impairments. The goal is to improve communication for people with these impairments.

Eligible Conditions
  • Parkinson's Disease
  • ALS (Amyotrophic Lateral Sclerosis)
  • Multiple System Atrophy
  • Locked-in Syndrome
  • Brain Stem Stroke
  • Adult Brain Tumors
  • Muscular Dystrophy
  • Spinal Cord Injury

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

4 Primary · 0 Secondary · Reporting Duration: 12 data collection sessions over 12 weeks (1 session/week) to assess change

Week 12
Information transfer rate
Typing Accuracy
Typing Speed
User experience

Trial Safety

Safety Progress

1 of 3

Trial Design

4 Treatment Groups

Adaptive signal modeling
1 of 4
Active querying techniques
1 of 4
Language modeling
1 of 4
BCI-FIT multi-modal configuration
1 of 4

Experimental Treatment

60 Total Participants · 4 Treatment Groups

Primary Treatment: BCI-FIT adaptive signal modeling · No Placebo Group · N/A

Adaptive signal modeling
Behavioral
Experimental Group · 1 Intervention: BCI-FIT adaptive signal modeling · Intervention Types: Behavioral
Active querying techniques
Behavioral
Experimental Group · 1 Intervention: BCI-FIT active querying · Intervention Types: Behavioral
Language modeling
Behavioral
Experimental Group · 1 Intervention: BCI-FIT language modeling · Intervention Types: Behavioral
BCI-FIT multi-modal configuration
Behavioral
Experimental Group · 1 Intervention: BCI-FIT multi-modal access · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 12 data collection sessions over 12 weeks (1 session/week) to assess change

Who is running the clinical trial?

Oregon Health and Science UniversityLead Sponsor
895 Previous Clinical Trials
6,831,245 Total Patients Enrolled
Melanie Fried-Oken, PhDPrincipal InvestigatorOregon Health and Science University

Eligibility Criteria

Age 18 - 89 · All Participants · 10 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You have adequate visuospatial skills to select letters, words, or icons to copy or generate messages.
You live within a 2-hour drive of OHSU or are willing to travel to OHSU.
You are between the ages of 18 and 89 years.
You have adequate visuospatial skills to select letters, words or icons to copy or generate basic messages.

Who else is applying?

What state do they live in?
New York100.0%
What site did they apply to?
Oregon Health & Science University100.0%
What portion of applicants met pre-screening criteria?
Met criteria100.0%